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Abstract 
Aims: To develop a rapid method to quantify the attachment of the cystic fibrosis (CF) 
pathogen, Burkholderia multivorans, to lung epithelial cells (16HBE14o-) using real-time 
PCR with a view to monitoring potential inhibition of lung cell attachment.   
Methods and Results:   Mammalian and bacterial DNA were purified from bacteria attached 
to lung epithelial cells.  The relative amount of bacteria attached was determined by 
amplification of the recA gene relative to the human GAPDH gene, in the presence of SYBR 
Green
®
.   The method was thoroughly validated and shown to correlate well with traditional 
plating techniques.   Inhibition of bacterial attachment with simple sugars was then evaluated 
by real-time PCR. Of the sugars examined, pre-incubation of B. multivorans with lactose, 
mannose and xylitol all decreased bacterial adherence to 16HBE14o- cells, while glucose and 
galactose had no significant effect.  Pre-incubation with lactose had the greatest effect, 
resulting in reduced adhesion to 35% of untreated controls. 
Conclusions:  This method can be used to quickly and effectively screen novel agents with 
higher affinities for bacterial adhesins.   
Importance and Significance:   This method will enable the rapid development of novel 
agents to inhibit colonisation by this pathogen from the environment.   
 
Keywords:  bacterial adhesion; Burkholderia cepacia complex; Cystic fibrosis; lung 
epithelial cells; real-time PCR.   
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Introduction   
Chronic lung infection in cystic fibrosis (CF) patients has a major impact on the 
mortality and quality of life of these patients.  A hierarchy of pathogens are acquired 
throughout a patient’s life and the majority of those acquired in later years are inherently 
antimicrobial resistant.  These include Pseudomonas aeruginosa and members of the 
Burkholderia cepacia complex (Bcc).  In particular, multiple mechanisms of resistance to 
multiple antibiotics exist among strains of the Bcc (Mahenthiralingam et al., 2005), and 
consequently this pathogen is rarely eradicated once a patient has been colonised.   In spite of 
strict segregation measures, Bcc continues to be acquired from the environment (Baldwin et 
al., 2007).   Rather than antibiotic therapy, a more effective approach would be to prevent 
colonisation by topical application of biodegradable binding inhibition agents (McClean and 
Callaghan, 2009).   
Previously, it has been shown that Bcc strains bound to many glycolipid receptors, 
including asialoGM1, asialoGM2 and globosides, on lung epithelia (Krivan et al., 1988a; 
Krivan et al., 1988b).  However, the complete elucidation and identification of these 
receptors has yet to be determined.  In the absence of clear identification of the actual 
receptors, screening a range of glycoconjugates for their potential to inhibit or compete with 
Bcc for binding sites, represents an alternative approach to the discovery of prophylactic 
treatments to prevent colonization.  Efficient identification of lead adhesion-inhibitor 
candidates requires a quantitative method which is reliable, reproducible and relatively quick 
to perform.   Traditional microbiological techniques for quantitating bacteria can be 
cumbersome, labour intensive and time consuming due to the extensive dilutions of bacteria 
that must be prepared, plated and subsequently counted, particularly if a large number of 
compounds are being analysed.  Other potentially more expedient approaches such as using 
bacterial specific enzyme activity to quantitate bacteria present (e.g. urease) were developed 
 4 
in our laboratory, but proved unsatisfactory due to an inability to clearly distinguish between 
the bacterial cells and background due to lung epithelial cells.  Enzyme-linked 
immunosorbent assays (ELISA) were not suitable, due to a lack of commercially available 
antibody for this pathogen.  Furthermore, we have previously found that genetic manipulation 
of the Bcc strains with GFP or RFP as a means of quantitation of bacteria significantly altered 
the adhesion phenotype of the mutants (unpublished) and was therefore not suitable either.  
Therefore, we have designed a rapid, reliable molecular technique for the identification of 
Bcc adhering to lung epithelial cells in vitro.  
Quantitative real-time PCR was selected as a method for development due to its speed 
and specificity.  The method was developed based on that of Candela et al., (2005), however 
substantial alterations to the method were required in order to adapt it to the quantitation of 
Bcc on lung epithelial cells.  B. multivorans was the focus of these studies as it has recently 
become the most frequently isolated Burkholderia species on both sides of the Atlantic and is 
predominantly acquired from the environment (Baldwin et al., 2008).  The recA gene was 
used to quantify the number of bacterial cells and the human GAPDH gene was used as a 
housekeeping gene to normalise for differences in DNA isolation. The real-time method was 
successfully optimised, validated and used to assess the ability of simple sugars to reduce the 
adhesion of B. multivorans to lung epithelial cells.   
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Materials and Methods  
Bacterial strain and Epithelial Cells 
B. multivorans strain LMG13010, which is a member of the International 
Burkholderia cepacia Working Group panel, was used throughout.  It was obtained from the 
BCCM/LMG, University of Ghent, Belgium and was routinely grown on Burkholderia 
cepacia specific agar (BCSA), (Henry et al., 1997) or in Luria–Bertani (LB) broth at 37 oC.  
Overnight cultures were grown to an O.D.600nm of 0.6 and then diluted to a given 
concentration.  The lung epithelial cell line 16HBE14o
-
 was  kindly donated by Dr. Dieter 
Gruenert (University of California, San Francisco, UCSF) and maintained in fibronectin-
vitrogen coated flasks containing minimal essential medium (MEM)  plus 10 % (v/v) FBS as 
described previously (Cozens et al., 1994).  For adhesion assays, 16HBE14o
- 
cells were 
seeded on coated 24 well plates at 2.5×10
5 
cells ml
-1
 in supplemented MEM in the absence of 
antibiotics and incubated overnight at 37
o
C in 5 % CO2.  The bacteria (~5x 10
6 
CFU) were 
then applied to the cells in MEM only and the plate was centrifuged at 700 g for 5 min, to 
facilitate bacterial attachment.  The plate was incubated at 37
o
C in the presence of 5% CO2 
for 30 min and then washed vigorously three times with PBS to remove unbound bacteria. 
 
Relative quantitation of B. multivorans 
This method was based on a method relating to detection of bifidobacteria on Caco-2 
gastrointestinal epithelial cells (Candela et al., 2005).   The original method amplified 
bacterial DNA directly from a cell lysate using 5 % (w/v) SDS in 0.5 mol l
-1
 NaOH. 
However, due to issues with reproducibility when trying to quantitate bacterial DNA with this 
method, most likely as a result of lack of reproducibility in extraction of the bacterial 
template, an alternative strategy was developed.  These modifications involved: 1) DNA 
extraction using the Wizard
®
 Genomic DNA purification kit (Promega) as outlined in the 
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manufacturer’s instruction, to purify the template prior to amplification; 2) inclusion of poly 
acryl DNA carrier (Molecular Research Centre, Inc., 5ul, as per manufacturer’s instructions); 
and 3) a reference gene, GAPDH, was also used to normalise the level of bacterial DNA 
present with that of human DNA.   Forward and reverse primers to the B. multivorans recA 
gene and to the human GAPDH gene were designed (Table 1).  Amplification was carried out 
in a final volume of 20µl containing 10 µl SYBR Green PCR Mix (Roche), 379 nmol l
-1
 
GAPDH primers or 190 nmol l
-1
  RecA primers, and 4 µl of DNA.  The plate was centrifuged 
briefly for 1 min at 700 g.  Real-time PCR was carried out on 7300 Real-Time PCR System 
(Applied Biosystems). The samples were amplified in triplicate as follows:  10 min at 95
o
C 
for denaturation, followed by 40 cycles at 95
o
C for 15 sec and 66
o
C for 1 min.  The data was 
collected during the 66
o
C annealing/elongation phase.  A dissociation step was carried out for 
melting curve analysis. 
 
Efficiencies of GAPDH and recA amplification 
The Pfaffl equation (Pfaffl, 2001) was used to determine results incorporating the relative 
efficiencies of amplification of the target and reference genes.   Real-time PCR efficiencies 
(E) were acquired using a five-point standard curve with both GAPDH and recA gene primers 
to determine the slope.  The corresponding efficiencies were calculated according to the 
following equation:  Efficiency (E) = (10^
(-1/slope)
).  Using these calculated efficiencies, the 
relative amount of bacterial DNA was determined compared to human GAPDH based on the 
cycle threshold values of bacterial versus human genes (Pfaffl, 2001).   
 
 7 
Validation of real-time PCR quantification compared with traditional microbiological 
methods  
B. multivorans strain, LMG13010 was grown to an O.D.600nm of 0.6 and serially diluted to a 
final concentration range of 200 to 2x10
7
 CFU ml
-1
.  Each dilution was applied to 2.5 x 10
5
 
16HBE14o
- 
cells and lysed in either DNA lysis buffer (Wizard
®
 Genomic DNA purification 
kit (Promega)) or cell lysis buffer (PBS, 10 mmol l
-1
  EDTA, 0.25 % Triton X-100).  The 
DNA was isolated and quantified using real-time PCR described above.  For the 
microbiological method, the resulting lysate was serially diluted in Ringer’s solution and 
quantified by viable counts on LB agar after 48 h.  Correlation curves were plotted of 
bacterial dilution against the relative CFU obtained after logarithmic transformation and 
relative quantity based on real-time PCR. 
 
Sugar Competition Assays 
Sterile solutions (1 to 20 mmol l
-1
) of glucose, galactose, mannose, xylitol or lactose were 
prepared in MEM.  An overnight culture of LMG13010 was grown to an O.D.600nm of 0.6 and 
diluted to a final concentration of 5 x 10
6
 CFU ml
-1
.  Bacteria were pre-incubated with the 
sugar solutions for 30 min at 37
o
C with gentle shaking and then applied to the 16HBE14o- 
cells. The plate was centrifuged at 700 g for 5 min and incubated at 37
o
C in the presence of 
5% CO2 for 30 min. Cells were washed vigorously three times with PBS to remove unbound 
bacteria.  Real-time PCR was used for relative quantification or plate counts were obtained 
from serial diluted cell lysates as described previously.   
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Results 
Detection using amplification direct from cell lysate.  
Initial studies aimed to determine the levels of adherent bacteria by absolute quantitation, 
based on an adaptation of a previous method (Candela et al., 2005) and involved using a 
standard curve to enumerate unknown amounts of this strain attached to lung cells.   The 
original method involved direct amplification of bacterial DNA from a lysate prepared from 
mammalian cells plus attached bacteria.  However, results indicated that the lysis buffer did 
not appear to lyse the bacteria adequately or that the sample was too complex for adequate 
polymerisation, as indicated by high Cycle threshold (Ct) values (>35 cycles for 2 x 10
5
 
bacteria). In addition, the standard curves obtained from triplicate samples over a range of 
CFU ml
-1
 were not linear (typical r
2
 = 0.247, data not shown).  Furthermore, major issues 
with reproducibility were encountered with some replicates of many samples not being 
amplified, indicating that even where adequate lysis took place, the lysis buffer was not 
suitable for reliable amplification.  A comparable standard curve prepared with stepwise 
dilutions of purified bacterial DNA resulted in a straight-line curve with a reported r
2
 value of 
greater than 0.97, indicating that the issues were associated with the matrix and not due to the 
target DNA or primers.   
 
Modification of real-time PCR method 
The method was adapted in two ways to improve the accuracy and reproducibility of bacterial 
quantification.  Firstly, a DNA extraction step including the use of a DNA carrier was 
employed to improve the quantity and quality of the template. It was also decided to use a 
relative quantification method with the human GAPDH gene as a reference gene in order to 
improve the reproducibility, particularly at lower CFU levels.  The GAPDH gene controlled 
for differences in total DNA extraction, as its quantitation should be constant for all wells 
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plated with the same lung cell number.  Strict conditions were employed in this assay to 
prevent the recA bacterial primers binding non-specifically to the human template.  This 
included a low concentration of primer (190nM) and a very high annealing and elongation 
temperature of 66
o
C despite primer melting temperatures of approximately 59
o
C.  The 
specificity of the amplification was demonstrated by melting curve analysis (Fig 1a).  Only 
one fluorescence peak was detected even at minimal levels of recA template (from 200 CFU).  
The product size of the amplicon was also verified on a 2% agarose gel (Fig 1b). 
 
Pfaffl Method of Quantification 
Primer efficiencies for both the target and reference genes were calculated by amplifying 
triplicate standards on five point standard curves in three independent experiments.  
Correlation coefficients were greater than 0.99 in each case (Fig 1c).  The average slopes and 
the subsequent efficiency value for the human GAPDH and bacterial recA genes are shown in 
Table 1.   According to criteria described by Pfaffl (2001), the inter- and intra-assay 
coefficients of variation for each primer measured over the range of concentrations examined 
in the standard curve (Table 1) are considered low for this assay. 
 
Validation of Real-Time Quantitative Method and Comparison to Traditional 
Microbiological Techniques 
To validate the real-time method of quantitation, a range of 10-fold dilutions of bacteria were 
mixed with human cells and the combined DNA was isolated in order to confirm that there 
was no interference from the human cells, or any PCR inhibitors in the extracted DNA.  The 
real-time PCR technique was able to reliably detect bacterial DNA down to ~200 CFU and a 
correlation coefficient value of R
2
 = 0.9997 was obtained (Fig 2A) over this 5 log range.  
Concomitantly, duplicate samples of a range of CFU of bacteria (200 to 2x10
7
 CFU) were 
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added to epithelial cells and were lysed using an EDTA/ Triton X-100-based lysis buffer. The 
resulting lysate was serially diluted and plated on LB agar for 48 h.  The number of CFU 
obtained confirmed that the ten-fold dilutions were comparable to that of the real-time PCR 
method (Fig 2B).   
 
Adhesion of B. multivorans to Lung Epithelial Cells: Sugar Competition Studies 
Sugar competition studies were used to determine if the method could be applied to 
quantitation of the inhibition of adhesion of B. multivorans to lung epithelial cells in the 
presence of a series of mono- and di-saccharides.  Bcc strains have been shown to bind to the 
sugar groups of gangliosides (Krivan et al., 1988b).  Pre-incubation of the bacteria with sugar 
molecules could therefore block receptors on the bacterial cell, inhibiting subsequent binding.  
Competition with lactose was most effective of all 5 sugars examined, showing a 
concentration-dependent inhibition of adhesion at concentrations from 10 mmol l
-1
 to  20 
mmol l
-1 
(Fig 3).  At the highest concentration, the level of bacterial adhesion was 35% of the 
control (p<0.001).  Pre-incubation with mannose and xylitol both had an effect at a single 
concentration (5 mmol l
-1
   and 10 mmol l
-1
, respectively), again reducing adhesion to 
approximately 60% of the control (p<0.05) in both cases.  Statistically significant effects 
were not observed at the other concentrations examined. Pre-incubation of B. multivorans 
with glucose had no effect over a range of concentrations and although galactose appeared to 
inhibit adhesion at a concentration of 20mmol l
-1
  to levels approximately 60% of that of the 
control, this was not statistically significant.  The coefficients of variation for both intra-assay 
variability and inter-assay variability were low for the control untreated samples (<2.33 % for 
intra-assay variability and <3.61 % for inter-assay variability for both genes).  ANOVA 
analysis demonstrated statistically significant inhibition of bacterial attachment with simple 
sugar molecules as shown in Fig 3.  
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For the purposes of comparison, three of the sugars, mannitol, xylitol and lactose were also 
tested using traditional plating methods.  These data were comparable to the real-time method 
and confirmed that lactose inhibited the % bacterial cell binding at 10 mmol l
-1
 (P<0.01) and   
20mmol l
-1
 (P<0.001), however neither mannitol nor xylitol showed any significant effect on 
B. multivorans binding.     
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Discussion 
We have designed a rapid, reliable molecular technique that can be utilised in vitro to detect 
B. multivorans adhering to epithelial cells.  This technique, which was validated down to a 
level of 200 CFU of bacteria, has been shown to yield comparable results to those of the 
traditional plate count method.   It was also less cumbersome and more reliable than the 
traditional method, due to the poor growth of Bcc strains.   
The concentrations of simple sugars that were required to inhibit bacterial attachment 
are considerably high.  However, it has been recently demonstrated that inhalation of simple 
sugars (fucose and galactose),  administered to patients at concentrations of 0.1 mol l
-1
  each, 
was a safe and effective measure to reduce P. aeruginosa counts in CF patients (Hauber et 
al., 2008).  Inhibition of adherence of several respiratory pathogens by common 
oligosaccharides has also previously been demonstrated (Thomas and Brooks, 2004).  
Maximal inhibition of the order of 1 log of CFU applied was achieved with concentrations of 
oligosaccharides in the millimolar range.  However, their method relied on culture of serial 
dilutions of bacterial-epithelial cell lysates. Many pathogens are difficult to culture, giving 
unreliable quantification of low bacterial numbers (Huijsdens et al., 2002).  The method 
described in this study will be more reliable for these types of species.  It is hoped that novel 
glycoconjugates can be designed with better affinities for bacterial adhesins which may show 
even greater efficacies, reducing attachment by several logs.  The linearity of this method 
over 5 log CFU range clearly demonstrates the suitability of this method to screen such novel 
glycoconjugates as potential inhibitors of bacterial attachment.   In particular, the efficacy of 
inhibitors that reduce adhesion by several log of CFU will be quantifiable using this method.  
Furthermore, it will not be necessary to apply extremely high (and not necessarily clinically 
relevant) levels of bacteria in order to enable accurate detection of inhibition in order to test 
these agents.    
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 We propose that the technique described herein could also be adapted for a number of other 
in vitro assays carried out to determine the virulence of bacteria e.g. adhesion, host cell 
invasion, translocation across the epithelium or intracellular growth.  All of these assays 
routinely rely on microbial culture as their endpoint and are inherently variable (McClean and 
Callaghan, 2009).  Primers can be designed against any bacterial species and their levels 
interacting with host cells quantified.   Displacement of colonising bacteria by competing 
bacterial pathogens could also be quantified by a method such as this.  In the future, we will 
use this method for screening of novel carefully designed glycoconjugates with potentially 
higher affinities for bacterial adhesins.   
 
Acknowledgements.   
This study was supported by the by PRTLI Cycles 3 & 4 (supported by the European Union 
Regional Development Plan, the Irish Government National Development Plan 2007-2013 
and administered by the Higher Education Authority in Ireland) and by the Technology 
Sector Research Post-graduate R&D Skills Programme (PRDSP),  Strand I.   We thank Dr 
Dieter Gruenert for kindly providing us with the 16HBE14o- cells and the Belgian 
Coordinated Microbiology Collection, Brussels, Belgium, for providing the B. multivorans  
strain.    
 
 
 14 
References   
 
Baldwin, A., Mahenthiralingam, E., Drevinek, P., Pope, C., Waine, D.J., Henry, D.A., Speert, 
D.P., Carter, P., Vandamme, P., Lipuma, J.J. and Dowson, C.G. (2008). Elucidating 
Global Epidemiology of Burkholderia multivorans in Cases of Cystic Fibrosis by 
Multilocus Sequence Typing. J Clin Microbiol 46, 290-295. 
Baldwin, A., Mahenthiralingam, E., Drevinek, P., Vandamme, P., Govan, J.R., Waine, D.J., 
LiPuma, J.J., Chiarini, L., Dalmastri, C., Henry, D.A., Speert, D.P., Honeyborne, D., 
Maiden, M.C.J. and Dowson, C.G. (2007). Environmental Burkholderia cepacia 
Complex isolates in human infections. Emerging Infectious Diseases 13, 458-461. 
Candela, M., Seibold, G., Vitali, B., Lachenmaier, S., Eikmanns, B.J. and Brigidi, P. (2005). 
Real-time PCR quantification of bacterial adhesion to Caco-2 cells: competition 
between bifidobacteria and enteropathogens. Res Microbiol 156, 887-895. 
Cozens, A.L., Yezzi, M.J., Kunzelmann, K., Ohrui, T., Chin, L., Eng, K., Finkbeiner, W.E., 
Widdicombe, J.H. and Gruenert, D.C. (1994). CFTR expression and chloride 
secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell 
Mol Biol 10, 38-47. 
Hauber, H.P., Schulz, M., Pforte, A., Mack, D., Zabel, P. and Schumacher, U. (2008). 
Inhalation with fucose and galactose for treatment of Pseudomonas aeruginosa in 
cystic fibrosis patients. Int J Med Sci 5, 371-376. 
Henry, D.A., Campbell, M.E., LiPuma, J.J. and Speert, D.P. (1997). Identification of 
Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple 
new selective medium. J Clin Microbiol 35, 614-619. 
Huijsdens, X.W., Linskens, R.K., Mak, M., Meuwissen, S.G., Vandenbroucke-Grauls, C.M. 
and Savelkoul, P.H. (2002). Quantification of bacteria adherent to gastrointestinal 
mucosa by real-time PCR. J Clin Microbiol 40, 4423-4427. 
Krivan, H.C., Ginsburg, V. and Roberts, D.D. (1988a). Pseudomonas aeruginosa and 
Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to 
gangliotetraosylceramide (asialo GM1) and gangliotriaosylceramide (asialo GM2). 
Arch Biochem Biophys 260, 493-496. 
Krivan, H.C., Roberts, D.D. and Ginsburg, V. (1988b). Many pulmonary pathogenic bacteria 
bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some 
glycolipids. Proc Natl Acad Sci U S A 85, 6157-6161. 
Mahenthiralingam, E., Urban, T.A. and Goldberg, J.B. (2005). The multifarious, 
multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 3, 144-156. 
McClean, S. and Callaghan, M. (2009). Burkholderia cepacia complex: epithelial cell-
pathogen confrontations and potential for therapeutic intervention. J Med Microbiol 
58, 1-12. 
Pfaffl, M.W. (2001). A new mathematical model for relative quantification in real-time RT-
PCR. Nucleic Acids Res 29, e45. 
Thomas, R. and Brooks, T. (2004). Common oligosaccharide moieties inhibit the adherence 
of typical and atypical respiratory pathogens. J Med Microbiol 53, 833-840. 
 
  
 
 15 
 
Table 1: Sequences of primers used in the real-time PCR assay and respective primer 
analysis data.   
 
 
Target 
species 
Gene Primer Primer sequence (5’ to 3’) 
 
Slope Efficiency Intra-
assay 
CV(%) 
Inter-
assay 
CV(%) 
B. 
multivorans 
recA 
  
Forward TGGACACGACCTGGATGT 
3.872 1.81 <2.76 <4.53 
Reverse ATGACCGCCGAGAAGAG 
Human 
GAPDH 
 
Forward CCCCTTCATACCCTCACGTA 
3.206 2.05 <1.92 <3.83 
reverse GACAAGCTTCCCGTTCTCAG 
* CV:  Coefficient of variation.  Each value represents the mean of three independent 
experiments.   
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Legends 
 
Figure 1.  A) Melting curve analysis on samples containing a range of bacterial CFU (0 to 2 
x 10
7
) in the presence of human lung cells.    A single fluorescence peak demonstrates recA 
primer specificity; no fluorescence is detected from human cells in the absence of bacterial 
template.  B) Agarose gel (2%) of GAPDH (2 to 4) and recA gene (5 to 7) PCR products.  
Lane 1:  100bp marker, Lanes 2 & 5: no template control; lanes 3 & 6: product from 2 x 10
7
 
CFU in the presence of lung epithelial cells; Lanes 4 and 7: epithelial cells only.  C).  Serial 
dilutions of  2 x 10
7
 CFU were applied to 2.5 x 10
5
 human cells to demonstrate the linear 
range of the assay for both primers, recA () and GAPDH ().    
 
Figure 2:  Correlation between the bacterial counts obtained in each assay by either relative 
quantification as determined by Real-time PCR () or the absolute quantification as 
determined by traditional plating methods using colony counts (o) and the actual bacterial 
CFU applied from three independent experiments.  The dotted line represents the theoretical 
values that should be obtained based on the numbers of bacteria applied.   
 
Figure 3. Competition studies with simple sugars as determined by real-time PCR analysis 
(A) or plate counts (B).  Pre-incubation with simple sugars inhibited subsequent adhesion of 
B. multivorans to lung epithelial cells.  Bars represent the mean % binding relative to 
inhibitor free control (100%) as follows: 1mM (dark); 5mM (white); 10mM (striped) and 
20mM (bar) from three separate experiments for each monosaccharide. Error bars represent 
the standard error of the mean (SEM). * p<0.05, ** p<0.01, ***p<0.001 using a one-way 
ANOVA and Tukey’s post-test (excluding values at 1mM concentration), compared to 
inhibitor free control. 
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Figure 1.  
A) 
 
 
 
B) C) 
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Figure 2
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